Concepedia
Statistics
Publications
2
Citations
66
H-Index
Active since
2019
Affiliations
Vrije Universiteit Brussel(Current)
Universitair Ziekenhuis Brussel
Centre Hospitalier Universitaire Brugmann
Laïla Ben Salama is an author at Vrije Universiteit Brussel specializing in glioblastoma immunotherapy, oncology, and medicine.
Publications per year
2019–2020
Axitinib plus avelumab in the treatment of recurrent glioblastoma: a stratified, open-label, single-center phase 2 clinical trial (GliAvAx)
Gil Awada, Laïla Ben Salama, Jennifer Cremer et al. · Journal for ImmunoTherapy of Cancer · 2020 · 55 citations · Full text
Medicine, Oncology, Pharmacology +17
GLIAVAX: A stratified phase II clinical trial of avelumab and axitinib in patients with recurrent glioblastoma.
Bart Neyns, Laïla Ben Salama, Gil Awada et al. · Journal of Clinical Oncology · 2019 · 11 citations
1–2 of 2